Recent Finacing
Recent Raise
FluimediX develops the NanoCycler, a point-of-care diagnostic platform that detects single-nucleotide polymorphisms and is being translated into targeted clinical tests such as a Warfarin metabolism assay.
Focus Areas
Recent Investors
Funding round
Investor